MAZE·578784100·US·equity·Healthcare - Biotechnology-13D/G
MAZE (MAZE THERAPEUTICS INC) is held by 88 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($85.3M), BlackRock, Inc. ($76.7M), Alphabet Inc. ($41.4M). Net institutional sentiment: Bullish.
See how MAZE's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer